Aldesleukin Terminated Phase 2 Trials for Metastatic Uveal Melanoma / Metastatic Ocular Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01814046Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma